These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 16938518)

  • 1. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Lòpez Beltran A; Cheng L; Montorsi F; Scarpelli M
    Eur Urol; 2007 Dec; 52(6):1682-9. PubMed ID: 17368711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.
    Barbisan F; Mazzucchelli R; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montorsi F; Montironi R
    Eur Urol; 2009 Jul; 56(1):105-12. PubMed ID: 18468781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens.
    Montironi R; Mazzucchelli R; Santinelli A; Scarpelli M; Beltran AL; Bostwick DG
    Hum Pathol; 2005 Jun; 36(6):646-54. PubMed ID: 16021571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-2 expression and gene amplification in high-grade PIN and prostate cancer.
    Montironi R; Mazzucchelli R
    Arch Ital Urol Androl; 2006 Dec; 78(4):135-9. PubMed ID: 17269616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis.
    Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Hum Pathol; 2011 Dec; 42(12):1931-6. PubMed ID: 21676431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
    Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
    Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer.
    Santinelli A; Mazzucchelli R; Barbisan F; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Am J Clin Pathol; 2007 Oct; 128(4):657-66. PubMed ID: 17875519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer.
    Morichetti D; Mazzucchelli R; Stramazzotti D; Santinelli A; Lopez-Beltran A; Scarpelli M; Bono AV; Cheng L; Montironi R
    BJU Int; 2010 Oct; 106(7):1072-80. PubMed ID: 20201837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 protein expression and gene amplification in androgen-independent prostate cancer.
    Reese DM; Small EJ; Magrane G; Waldman FM; Chew K; Sudilovsky D
    Am J Clin Pathol; 2001 Aug; 116(2):234-9. PubMed ID: 11488070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Int J Immunopathol Pharmacol; 2009; 22(3):755-62. PubMed ID: 19822092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?
    Mazzucchelli R; Barbisan F; Scarpelli M; Lopez-Beltran A; van der Kwast TH; Cheng L; Montironi R
    Am J Clin Pathol; 2009 Feb; 131(2):279-83. PubMed ID: 19141388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.
    Han KS; Jeong IG; Joung JY; Yang SO; Chung J; Seo HK; Park WS; Lee KH
    Urology; 2007 Dec; 70(6):1100-3. PubMed ID: 18158026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
    Minner S; Jessen B; Stiedenroth L; Burandt E; Köllermann J; Mirlacher M; Erbersdobler A; Eichelberg C; Fisch M; Brümmendorf TH; Bokemeyer C; Simon R; Steuber T; Graefen M; Huland H; Sauter G; Schlomm T
    Clin Cancer Res; 2010 Mar; 16(5):1553-60. PubMed ID: 20179235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
    Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
    Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.